Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs - an open-label study

Rafael Stryjer*, Dana Budnik, Tania Ebert, Tamar Green, Lea Polak, Shira Weizman, Baruch Spivak

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs - an open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences